Sharepoint Solutions
PRODUCTS
-
Eliminate errors and accelerate production with MasterControl MES.
MasterControl Manufacturing Excellence is a modern manufacturing execution system (MES) that has helped hundreds of manufacturers eliminate millions of errors and deliver products to the market 70% faster.
It’s time to modernize your manufacturing operations – from digital work instructions and production records (EBR/eDHR) to electronic logbooks and equipment tracking – and see how MasterControl Manufacturing Excellence software can help you run faster, leaner, and smarter.
-
ReciBioPharm offers industry-leading biologics development services to support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.
-
The Composable MES for Pharmaceuticals provides a starting point for you to implement a tailored, connected production system with end-to-end traceability and right-the-first-time electronic batch records (eBR).
-
Used Kikusui tablet in tablet press, model Aquarius G-J/DC, 36 station, keyed upper punch guides, B tooled, 100 kN pre-compression, 100 kN main compression, 16mm max tablet diameter, 18mm max depth of fill, rated up to 259,200 tablets/hour, with DC module for core feeder, 4-15mm core depth adjustment, with integrated primary and secondary powder feed hoppers, and core feed hopper, project# 1-6302, built 2009.
-
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
WHITE PAPERS AND CASE STUDIES
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Selecting A New Sporicidal Disinfectant: What The Cleanroom Manager Needs To Know
This guide helps cleanroom managers evaluate sporicides by efficacy, safety, and compatibility to ensure contamination control without compromising operational integrity.
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
How To Manage A Drug Product In A Medical Device Environment
Discover how ProPharma successfully ensured GMP and GDP compliance for a drug product within a medical device environment.
-
Decentralized Trials For Duchenne Muscular Dystrophy
Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.
-
A Comprehensive Planning Approach For Cancer Antibody
Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.
-
Medical Writing Support Relieves A Burdensome Review
Unearth how medical writing and project management teams were able to streamline the development and review of a critical marketing application document.
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
The Foundation Of Peak Performance
In this case study, read about an underdrain system that continues to operate as expected after 16 years of operation and appears to be in perfect condition.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
Container Selection For A Highly Sensitive Drug Product: A Success Story
Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.
NEWS
-
Biden-Harris Administration Announces $3.6B For Water Infrastructure Through Investing in America Agenda10/23/2024
the U.S. Environmental Protection Agency announced $3.6B in new funding under the Biden-Harris Administration’s Bipartisan Infrastructure Law to upgrade water infrastructure and keep communities safe.
-
Spraying Methyl Jasmonate On Fruit Trees Boosts Harvest2/26/2025
Spraying persimmon trees with methyl jasmonate (MeJA) can result in healthier, longer lasting fruit, with increased antioxidants a new Edith Cowan University (ECU) study has found.
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
EGLE Announces $17.7M In MI Clean Water Grants To Help Communities Upgrade Water Infrastructure, Protect Health And Environment1/5/2024
Upgrades to wastewater management around Lake Mitchell and lead service line removals in Eastpointe are among more than $17 million in state grants recently awarded to Michigan communities.
-
EPA Announces $89M Loan To Enhance Wastewater Management In King County12/18/2024
Today, the U.S. Environmental Protection Agency announced an $89M loan to King County, Washington, to help upgrade several wastewater treatment systems. Provided by the EPA’s Water Infrastructure Finance and Innovation Act (WIFIA) loan program, this funding will support projects that improve the reliability of reclaimed water available for use and enhance the system’s resiliency to future seismic events.